Skip to main content
OpenTrials
Completed

NCT Number: NCT01522157

A Randomized Cross-over Trial of the Postprandial Effects of Three Different Diets in Patients With Type 2 Diabetes

The trial will study the acute metabolic effects of three different types of diet: low-fat diet, low-carbohydrate diet and Mediterranean diet. About 20 patients with diabetes mellitus type 2 will be recruited and each of them will be given each type of diet on three different days. Menus with the same energy content but with different content of fat, carbohydrate and protein are designed. Breakfast and lunch are served for the patients each day of testing. Laboratory samplings are performed six times during the day. The order of the dietary intervention is randomized for each patient.

The investigators suppose to find different reaction in plasma glucose and lipids depending on the type of diet.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Type 2 Diabetes Mellitus Diabetes Mellitus Diabetes Mellitus, Type 2 Endocrine System Diseases Glucose Metabolism Disorders Metabolic Diseases Nutritional and Metabolic Diseases

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Department of Medical and Health Sciences, Linköping University

Linköping, S-59183, Sweden

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Diabetes mellitus type 2

Exclusion criteria

  • Treatment with insulin or sulfonylurea

Treatment and study plan

Low-fat diet

Dietary Supplement

Low-fat Diet is provided for a breakfast and a lunch.

Low-carbohydrate Diet

Dietary Supplement

Low-carbohydrate Diet is provided for a breakfast and a lunch.

Mediterranean diet

Dietary Supplement

Mediterranean Diet is provided for a breakfast and a lunch.

Primary outcomes

  1. P-glucose

    Time frame: 6 months

    mmol/l

  2. P-Triglycerides

    Time frame: 6 months

    mmol/l

Secondary outcomes

  1. P-Cholesterol

    Time frame: 6 months

    mmol/l

  2. P-LDL-Cholesterol

    Time frame: 6 months

    mmol/l

  3. P-HDL-Cholesterol

    Time frame: 6 months

    mmol/l

Sponsors and collaborators

Lead sponsor

Vårdcentralen Lyckorna

Other

Registry information

Important dates

Study start
2012
Primary completion
2012
Study completion
2012
First posted
Jan 31, 2012
Registry last updated
Dec 2, 2013

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.